[go: up one dir, main page]

IT1291633B1 - Uso dell'alfa-metil-p-tirosina per inibire la produzione di melanina nei melanociti dell'iride - Google Patents

Uso dell'alfa-metil-p-tirosina per inibire la produzione di melanina nei melanociti dell'iride

Info

Publication number
IT1291633B1
IT1291633B1 IT97MI000939A ITMI970939A IT1291633B1 IT 1291633 B1 IT1291633 B1 IT 1291633B1 IT 97MI000939 A IT97MI000939 A IT 97MI000939A IT MI970939 A ITMI970939 A IT MI970939A IT 1291633 B1 IT1291633 B1 IT 1291633B1
Authority
IT
Italy
Prior art keywords
melanin
iris
thyrosine
melanocytes
inhibit
Prior art date
Application number
IT97MI000939A
Other languages
English (en)
Inventor
Filippo Drago
Original Assignee
Pharmaconsult S A S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaconsult S A S filed Critical Pharmaconsult S A S
Publication of ITMI970939A0 publication Critical patent/ITMI970939A0/it
Priority to IT97MI000939A priority Critical patent/IT1291633B1/it
Priority to AU76462/98A priority patent/AU732046B2/en
Priority to PT98924164T priority patent/PT977575E/pt
Priority to AT98924164T priority patent/ATE227577T1/de
Priority to CA002287887A priority patent/CA2287887A1/en
Priority to JP54502598A priority patent/JP2001521540A/ja
Priority to DE69809408T priority patent/DE69809408T2/de
Priority to CN98804999A priority patent/CN1255064A/zh
Priority to NZ500435A priority patent/NZ500435A/en
Priority to US09/403,524 priority patent/US6359001B1/en
Priority to PCT/EP1998/002365 priority patent/WO1998047515A1/en
Priority to EP98924164A priority patent/EP0977575B1/en
Priority to SI9830312T priority patent/SI0977575T1/xx
Priority to RU99124771/14A priority patent/RU2218159C2/ru
Priority to ES98924164T priority patent/ES2187028T3/es
Priority to SK1424-99A priority patent/SK284255B6/sk
Priority to IL13250398A priority patent/IL132503A/en
Priority to KR1019997009782A priority patent/KR20010020202A/ko
Priority to PL98336386A priority patent/PL189304B1/pl
Priority to HU0002100A priority patent/HUP0002100A3/hu
Priority to DK98924164T priority patent/DK0977575T3/da
Publication of ITMI970939A1 publication Critical patent/ITMI970939A1/it
Application granted granted Critical
Publication of IT1291633B1 publication Critical patent/IT1291633B1/it
Priority to NO995122A priority patent/NO995122L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT97MI000939A 1997-04-22 1997-04-22 Uso dell'alfa-metil-p-tirosina per inibire la produzione di melanina nei melanociti dell'iride IT1291633B1 (it)

Priority Applications (22)

Application Number Priority Date Filing Date Title
IT97MI000939A IT1291633B1 (it) 1997-04-22 1997-04-22 Uso dell'alfa-metil-p-tirosina per inibire la produzione di melanina nei melanociti dell'iride
PCT/EP1998/002365 WO1998047515A1 (en) 1997-04-22 1998-04-21 THE USE OF α-METHYL-P-TYROSINE TO INHIBIT MELANIN PRODUCTION IN IRIS MELANOCYTES
SI9830312T SI0977575T1 (en) 1997-04-22 1998-04-21 The use of alpha-methyl-p-tyrosine to inhibit melanin production in iris melanocytes
AT98924164T ATE227577T1 (de) 1997-04-22 1998-04-21 Anwendung von alpha-methyl-p-tyrosine zur hemmung der melanin-produktion in irismelanozyten
CA002287887A CA2287887A1 (en) 1997-04-22 1998-04-21 The use of .alpha.-methyl-p-tyrosine to inhibit melanin production in iris melanocytes
JP54502598A JP2001521540A (ja) 1997-04-22 1998-04-21 虹彩メラノサイトにおけるメラニン生成を阻害するα−メチル−Ｐ−チロシンの使用
DE69809408T DE69809408T2 (de) 1997-04-22 1998-04-21 Anwendung von alpha-methyl-p-tyrosine zur hemmung der melanin-produktion in irismelanozyten
CN98804999A CN1255064A (zh) 1997-04-22 1998-04-21 α－甲基－对－酪氨酸抑制虹膜黑素细胞中黑色素的产生的用途
NZ500435A NZ500435A (en) 1997-04-22 1998-04-21 The use of alpha-methyl-p-tyrosine to inhibit melanin production in iris melanocytes
US09/403,524 US6359001B1 (en) 1997-04-22 1998-04-21 Use of α-methyl-p-tyrosine to inhibit melanin production in iris melanocytes
AU76462/98A AU732046B2 (en) 1997-04-22 1998-04-21 The use of alpha-methyl-p-tyrosine to inhibit melanin production in iris melanocytes
EP98924164A EP0977575B1 (en) 1997-04-22 1998-04-21 The use of alpha-methyl-p-tyrosine to inhibit melanin production in iris melanocytes
PT98924164T PT977575E (pt) 1997-04-22 1998-04-21 Utilizacao de alfa-metil-p-tirosina para inibir a producao de melanina nos melanocitos da iris
RU99124771/14A RU2218159C2 (ru) 1997-04-22 1998-04-21 ПРИМЕНЕНИЕ α-МЕТИЛ-п-ТИРОЗИНА ДЛЯ ИНГИБИРОВАНИЯ ПРОДУЦИРОВАНИЯ МЕЛАНИНА В МЕЛАНОЦИТАХ РАДУЖНОЙ ОБОЛОЧКИ
ES98924164T ES2187028T3 (es) 1997-04-22 1998-04-21 El uso de alfa-metil-p-tirosina para inhibir la produccion de melanina en melanocitos de iris.
SK1424-99A SK284255B6 (sk) 1997-04-22 1998-04-21 Použitie alfa-metyl-p-tyrozínu na inhibíciu produkcie melanínu v melanocytoch dúhovky
IL13250398A IL132503A (en) 1997-04-22 1998-04-21 The use of tyrosine inhibitors in the preparation of a drug that prevents the production of melanin in the melanocytes of the iris, which is caused by prostaglandin derivatives
KR1019997009782A KR20010020202A (ko) 1997-04-22 1998-04-21 홍채 멜라닌세포에서의 멜라닌 생성을 억제하기 위한 α-메틸-Ｐ-티로신의 용도
PL98336386A PL189304B1 (pl) 1997-04-22 1998-04-21 Zastosowanie alfa-metylo-p-tyrozyny do wytwarzania środka farmaceutycznego i kompozycja farmaceutyczna zawierająca alfa-metylo-p-tyrozynę
HU0002100A HUP0002100A3 (en) 1997-04-22 1998-04-21 The use of alpha-methyl-p-tyrosine to inhibit melanin production in iris melanocytes
DK98924164T DK0977575T3 (da) 1997-04-22 1998-04-21 Anvendelse af alfa-methyl-p-tyrosin til inhibering af melaninproduktion i irismelanocytter
NO995122A NO995122L (no) 1997-04-22 1999-10-21 Anvendelse av <alfa>-metyl-p-tyrosin for å inhibere melaninproduksjon i irismelanocytter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI000939A IT1291633B1 (it) 1997-04-22 1997-04-22 Uso dell'alfa-metil-p-tirosina per inibire la produzione di melanina nei melanociti dell'iride

Publications (3)

Publication Number Publication Date
ITMI970939A0 ITMI970939A0 (it) 1997-04-22
ITMI970939A1 ITMI970939A1 (it) 1998-10-22
IT1291633B1 true IT1291633B1 (it) 1999-01-11

Family

ID=11376994

Family Applications (1)

Application Number Title Priority Date Filing Date
IT97MI000939A IT1291633B1 (it) 1997-04-22 1997-04-22 Uso dell'alfa-metil-p-tirosina per inibire la produzione di melanina nei melanociti dell'iride

Country Status (22)

Country Link
US (1) US6359001B1 (it)
EP (1) EP0977575B1 (it)
JP (1) JP2001521540A (it)
KR (1) KR20010020202A (it)
CN (1) CN1255064A (it)
AT (1) ATE227577T1 (it)
AU (1) AU732046B2 (it)
CA (1) CA2287887A1 (it)
DE (1) DE69809408T2 (it)
DK (1) DK0977575T3 (it)
ES (1) ES2187028T3 (it)
HU (1) HUP0002100A3 (it)
IL (1) IL132503A (it)
IT (1) IT1291633B1 (it)
NO (1) NO995122L (it)
NZ (1) NZ500435A (it)
PL (1) PL189304B1 (it)
PT (1) PT977575E (it)
RU (1) RU2218159C2 (it)
SI (1) SI0977575T1 (it)
SK (1) SK284255B6 (it)
WO (1) WO1998047515A1 (it)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL145122A0 (en) 1999-03-05 2002-06-30 Procter & Gamble C16 unsaturated fp-selective prostaglandin analogs
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US9744237B2 (en) * 2009-01-29 2017-08-29 Kambiz Thomas Moazed Method and system for effecting changes in pigmented tissue
US20110280909A1 (en) * 2009-01-29 2011-11-17 Kambiz Thomas Moazed Method and system for effecting changes in pigmented tissue
US20120076848A1 (en) * 2009-07-22 2012-03-29 Kambiz Thomas Moazed Method and system for effecting changes in pigmented tissue
US20130183263A1 (en) 2012-01-17 2013-07-18 Steven Hoffman Pharmaceutical compositions and methods
US10646552B2 (en) 2012-01-17 2020-05-12 Tyme, Inc. Pharmaceutical compositions and methods
BR112014017613A2 (pt) 2012-01-17 2017-07-04 Tyme Inc composição farmacêutica, kit, método para tratar câncer em um indivíduo e método para reduzir a proliferação celular em um indivíduo
US10272068B2 (en) 2012-01-17 2019-04-30 Tyme, Inc. Pharmaceutical compositions and methods
US8481498B1 (en) 2012-01-17 2013-07-09 Steven Hoffman Pharmaceutical compositions and methods
US10751313B2 (en) 2013-10-22 2020-08-25 Yamo Pharmaceuticals Llc Compositions and methods for treating autism
US9763903B2 (en) 2013-10-22 2017-09-19 Steven Hoffman Compositions and methods for treating intestinal hyperpermeability
US9585841B2 (en) 2013-10-22 2017-03-07 Tyme, Inc. Tyrosine derivatives and compositions comprising them
US10813901B2 (en) 2013-10-22 2020-10-27 Yamo Pharmaceuticals Llc Compositions and methods for treating autism
US9326962B2 (en) 2013-10-22 2016-05-03 Steven Hoffman Compositions and methods for treating intestinal hyperpermeability
ES2738248B2 (es) * 2018-06-21 2023-03-10 Consejo Superior Investigacion Uso de inhibidores de la tirosina hidroxilasa para el tratamiento del aneurisma de aorta
CN112789045A (zh) 2018-07-19 2021-05-11 亚莫制药有限公司 用于治疗孤独症的组合物和方法
KR20220098682A (ko) 2019-05-14 2022-07-12 타임, 인크. 암을 치료하기 위한 조성물 및 방법
CN116035151A (zh) * 2023-01-18 2023-05-02 云南贝泰妮生物科技集团股份有限公司 一种刺梨闪释粉及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04117313A (ja) * 1990-09-06 1992-04-17 Kanebo Ltd 美白化粧料

Also Published As

Publication number Publication date
JP2001521540A (ja) 2001-11-06
HUP0002100A2 (hu) 2000-11-28
ITMI970939A0 (it) 1997-04-22
CN1255064A (zh) 2000-05-31
DE69809408T2 (de) 2003-07-10
IL132503A (en) 2004-06-20
ITMI970939A1 (it) 1998-10-22
PL189304B1 (pl) 2005-07-29
WO1998047515A1 (en) 1998-10-29
DK0977575T3 (da) 2003-03-10
AU7646298A (en) 1998-11-13
AU732046B2 (en) 2001-04-12
RU2218159C2 (ru) 2003-12-10
NO995122L (no) 1999-12-21
NZ500435A (en) 2001-09-28
SK142499A3 (en) 2000-09-12
IL132503A0 (en) 2001-03-19
HUP0002100A3 (en) 2003-05-28
PT977575E (pt) 2003-03-31
EP0977575B1 (en) 2002-11-13
ES2187028T3 (es) 2003-05-16
CA2287887A1 (en) 1998-10-29
SI0977575T1 (en) 2003-04-30
EP0977575A1 (en) 2000-02-09
NO995122D0 (no) 1999-10-21
US6359001B1 (en) 2002-03-19
DE69809408D1 (de) 2002-12-19
KR20010020202A (ko) 2001-03-15
PL336386A1 (en) 2000-06-19
ATE227577T1 (de) 2002-11-15
SK284255B6 (sk) 2004-12-01

Similar Documents

Publication Publication Date Title
IT1291633B1 (it) Uso dell&#39;alfa-metil-p-tirosina per inibire la produzione di melanina nei melanociti dell&#39;iride
UY26082A1 (es) Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica
ID28947A (id) Metode untuk meringankan inkontinensia uriner wanita
DK0671161T3 (da) Ectoin og ectoinderivater som fugtighedsgiver i kosmetikprodukter
ES2157684T3 (es) Composicion de blanqueo de la piel y/o de los cabellos.
ES2077827T3 (es) Composicion adelgazante a base de ginkgo biloba como alfa-2-bloqueadores.
DE69505651D1 (de) Hemmen von haarwuchs
SE9802206D0 (sv) Novel compounds
ES2187617T3 (es) Agentes antifungicos de hexapeptidos ciclicos.
IT1272290B (it) Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee
AR009763A1 (es) Utilizacion en una composicion como estimulador de tirosinasa de al menos un derivado de 3-oxido pirimidina, sustituido en la posicin 6
BR9903750B1 (pt) utilização não terapêutica de pelo menos um extrato de rosácea do gênero sanguisorba e processo cosmético de pigmentação da pele.
SE9904674D0 (sv) Novel compounds
IT1251838B (it) Uso della nimesulide nel trattamento della cataratta
IT1274157B (it) &#34;sale della l-carnitina e composizioni farmaceutiche che lo contengonoper il trattamento di affezioni cutanee&#34;
IT1302934B1 (it) Composizione per migliorare l&#39;aspetto di getti cementizi.
GEP20043231B (en) Resorcinol Composition
BR0112338A (pt) Composto, composição farmacêutica, e, uso de um composto
DE69914757D1 (de) Parfümzusammensetzung
AR008155A1 (es) Uso de un compuesto de formula i para preparar un medicamento util para tratar y prevenir la enfermedad cardiovascular post menopausica en mujeres.
IT1251497B (it) Uso di 1,2 dipalmitoil-l-alfa-fosfatidil-n,n-dimetiletanolammina, in composizioni dermatologiche
SE9802538D0 (sv) New pharmaceutically active compounds
IT1276040B1 (it) Uso della benzidamina nel trattamento di stati patologici causati dal tnf
MX9307834A (es) Derivados de 3-(quinolein-6-il-metil)-4h-imidazol-4-ona, su preparacion ysu aplicacion en terapeutica.
FR2637497B1 (fr) Installation de massage corporel par hydrotherapie notamment

Legal Events

Date Code Title Description
0001 Granted